T

Telcon RF Pharmaceutical Inc
KOSDAQ:200230

Watchlist Manager
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Watchlist
Price: 996 KRW Market Closed
Market Cap: 68.2B KRW

Gross Margin
Telcon RF Pharmaceutical Inc

24.8%
Current
24%
Average
24.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
24.8%
=
Gross Profit
10.2B
/
Revenue
41B

Gross Margin Across Competitors

No Stocks Found

Telcon RF Pharmaceutical Inc
Glance View

Market Cap
68.2B KRW
Industry
Electrical Equipment

TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.

Intrinsic Value
1 410.12 KRW
Undervaluation 29%
Intrinsic Value
Price
T
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
24.8%
=
Gross Profit
10.2B
/
Revenue
41B
What is the Gross Margin of Telcon RF Pharmaceutical Inc?

Based on Telcon RF Pharmaceutical Inc's most recent financial statements, the company has Gross Margin of 24.8%.

Back to Top